Antonella Favit-Van Pelt, MD, PhD, discusses the use of neuromodulation and neuroplasticity for addressing gait deficits in patients with multiple sclerosis.

When ocrelizumab became the first FDA-approved treatment for early forms of multiple sclerosis (MS) in 2017, it offered patients immense hope. The long-awaited drug is a monoclonal antibody that ...

Researchers reveal how activating the Egr-1 gene can help alleviate autoimmune inflammation via Foxp3 expression Autoimmune ...

Relapsing Multiple Sclerosis: Navigating Treatment Conundrums This activity is supported by an educational grant from Novartis Pharmaceuticals, Inc.

Autoimmune diseases, such as multiple sclerosis (MS), inflammatory bowel disease (IBD), and rheumatoid arthritis (RA), affect ...

There’s no cure for multiple sclerosis, but treatment can help slow the disease progression and reduce symptoms. Learn about these treatments and more.

Mona is a registered dietitian-nutritionist (RDN) and multiple sclerosis certified specialist (MSCS) who has been living with relapsing multiple sclerosis (MS) herself since 2008.

There are different types of MS. However, researchers are starting to use stages to measure disease progression. Learn more.

Aim This paper aims to systematically review studies investigating the strength of association between FMS composite scores and subsequent risk of injury, taking into account both methodological ...